Sarepta Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Sarepta Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Sarepta Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 198M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 198M 0 0% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 198M 0 0% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 198M 0 0% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 198M 0 0% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 198M 0 0% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 198M 0 0% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 198M 0 0% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 198M 0 0% Dec 31, 2022 10-K 2024-02-28
Q3 2022 198M 0 0% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 198M 0 0% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 198M 0 0% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 198M 0 0% Dec 31, 2021 10-K 2023-02-28
Q3 2021 198M 0 0% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 198M 0 0% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 198M +99M +100% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 198M 0 0% Dec 31, 2020 10-K 2022-03-01
Q3 2020 198M +99M +100% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 198M +99M +100% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 99M 0 0% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 198M +99M +100% Dec 31, 2019 10-K 2021-03-01
Q3 2019 99M 0 0% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 99M 0 0% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 99M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 99M 0 0% Dec 31, 2018 10-K 2020-02-26
Q3 2018 99M 0 0% Sep 30, 2018 10-Q 2018-10-31
Q2 2018 99M 0 0% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 99M 0 0% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 99M 0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 99M 0 0% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 99M 0 0% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 99M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 99M 0 0% Dec 31, 2016 10-K 2018-03-01
Q3 2016 99M 0 0% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 99M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 99M +49M +98% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 99M 0 0% Dec 31, 2015 10-K 2017-02-28
Q3 2015 99M +49M +98% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 99M +49M +98% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 50M 0 0% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 99M +49M +98% Dec 31, 2014 10-K 2016-02-25
Q3 2014 50M 0 0% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 50M 0 0% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 50M 0 0% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 50M 0 0% Dec 31, 2013 10-K 2015-02-26
Q3 2013 50M 0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 50M 0 0% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 50M -250M -83.3% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 50M 0 0% Dec 31, 2012 10-K 2014-03-03
Q3 2012 50M -250M -83.3% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 50M -250M -83.3% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 300M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 50M -150M -75% Dec 31, 2011 10-K 2013-03-15
Q3 2011 300M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 300M Jun 30, 2011 10-Q 2011-08-08
Q4 2010 200M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.